CDT EQUITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CDT EQUITY INC. (CDT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-08
- CDT EQUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- CDT EQUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- CDT EQUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was -5.60K shares.
- CDT EQUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 5.63K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: S-1 6 month − 10-Q 3 month · filed 2026-09-08 | 0.00 shares S-1 · filed 2026-09-08 | -5.60K shares derived: sum of 3 quarters · filed 2026-09-08 | 23.00 shares derived: sum of 4 quarters · filed 2026-09-08 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-07-15 | -5.60K shares derived: sum of 2 quarters · filed 2026-09-08 | 23.00 shares derived: sum of 3 quarters · filed 2026-09-08 | 23.00 shares derived: sum of 4 quarters · filed 2026-09-08 | |
| 2025-12-31 | -5.60K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | 23.00 shares derived: sum of 2 quarters · filed 2026-09-08 | 23.00 shares derived: sum of 3 quarters · filed 2026-09-08 | 23.00 shares S-1 · filed 2026-09-08 | 225.00 shares 10-K · filed 2026-04-15 |
| 2025-09-30 | 5.63K shares 10-Q · filed 2025-11-13 | 5.63K shares derived: sum of 2 quarters · filed 2026-09-08 | 5.63K shares 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | 0.00 shares derived: S-1 6 month − 10-Q 3 month · filed 2026-09-08 | 0.00 shares S-1 · filed 2026-09-08 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-07-15 | ||||
| 2024-12-31 | 2.00 shares S-1 · filed 2026-09-08 | 18.00 shares 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |